Home / Health / Guernsey faces pharmacist shortage impacting opioid treatment
Guernsey faces pharmacist shortage impacting opioid treatment
27 May
Summary
- Guernsey's opioid substitution treatment is under threat.
- A global pharmacist shortage limits local service capacity.
- Weekend treatment access is a significant struggle for patients.
The availability of Opioid Substitution Treatment (OST) in Guernsey is facing significant challenges due to a critical shortage of pharmacists. This global deficit in healthcare professionals limits the island's capacity to deliver vital services that support individuals dependent on drugs like heroin. OST aims to reduce the risks associated with illicit drug use and aid in complete opioid cessation through prescribed medications.
Public Health's 2025 Annual Report highlights the need for long-term, sustainable solutions to build resilience within community pharmacies. Ensuring consistent access to prescribed medications is paramount to prevent diversion to the black market. While the Community Drug and Alcohol Team has commendably reduced opioid addiction rates by half over the past eight years, ongoing issues persist.
Challenges are particularly acute during weekends, with only two pharmacies offering seven-day prescription services. This necessitates patients taking medications home, which introduces potential risks and complications. The Health Improvement Commission is striving for seven-day supervised consumption in the community, but the scarcity of pharmacists and pharmacies willing to offer continuous coverage presents a substantial hurdle for future strategies.
